-
ABOUT
- Who are we
- Objectives of the LabEx
- Laboratories and teams
- Directory Board
- Industrial collaborators
- Institutional and Financial Supports
- GOVERNANCE
- Organigram
- Steering committee
- Executive Committee
- External Scientific Advisory Board
- Institutional Board
- TRAINING
- CONFERENCES
- PROJECTS
- Post genomic data exploration
- Mechanisms of pathogenesis
- Parasite molecular and cellular biology
- Towards new intervention strategies against parasitic pathogens
- Plateforms
- VALORIZATION
-
ABOUT
- Who are we
- Objectives of the LabEx
- Laboratories and teams
- Directory Board
- Industrial collaborators
- Institutional and Financial Supports
- GOVERNANCE
Gerald Spaeth received a ERC Synergy grant
[Communiqué]
Gerald Spaeth, head of the "Molecular Parasitology and Signalling" unit at the Institut Pasteur Paris, has been awarded a Synergy grant from the European Research Council (ERC) for the project "DECOLeishRN - Decoding epistatic genome/RNome interactions in ekaryotic fitness gain using Leishmania parasites as a unique model system". This project is funded at over 9 millions Euros and will be conducted in collaboration with two Israeli teams led by Shulamit Michaeli (Bar-Ilan University) and Yitzhak Pilpel (Weizmann Institute of Science).
Exploiting the unique biology of the protozoan parasite Leishmania as a model system, the project will generate unprecedented insight into the role of genome instability in eukaryotic adaptation by combining experimental evolution, analyses of the non-coding RNA, network modelling and cutting-edge, single cell sequencing. The project aims to uncover the molecular filter that can mitigate toxic effects of genome instability while promoting beneficial ones, thus resolving a long-standing question in infection and cancer biology.
The six-year project (2023-2029) is poised to reveal complex and dynamic interactions between genomic, epitranscriptomic and phenotypic adaptation of these important parasites, and the role of stress-adapted ribosomes and non-coding RNAs – especially anti-sense regulators – that compensate for detrimental gene dosage changes. The scientists will further examine whether the parasite has the capacity to predict and prepare in advance to changes in environmental conditions and the switch between its hosts. The study of pathogen evolution within a mammalian host will provide an innovative framework for the discovery of complex biomarker candidates linked to Leishmania virulence and drug resistance. Exploiting genome instability for adaptation is common to other diseases-causing microbes and cancer. This ERC Synergy grant will thus deliver a blueprint to study how chaotic genome instability is harnessed for adaptation and to escape unfavorable environmental conditions.
Thursday, 24 October 2024PostDoc l Trypanosoma l Paris, FR
Postdoctoral position, Institut Pasteur, Paris, France A 24-month post-doctoral position starting on March 1st 2025 and funded by the French National Research Agency (ANR) is available in the Trypanosome...
Monday, 21 October 2024PostDoc x2 l Malaria l Montpellier, FR
Postdoctoral positions, LPHI Lab, Montpellier, France Two ERC-funded (JANUS 2024-2029) postdoc positions are open in the lab to study cell cycle regulation in malaria...
Tuesday, 01 October 2024PostDoc l Leishmania l Paris, FR
Postdoctoral position, Institut Pasteur, Paris, France A postdoc position is available at the Institut Pasteur Paris, in the signalling and host-parasite interactions research group, headed by Dr Najma Rachidi...
Monday, 01 July 2024Next Generation In Parasitology - Workshop
ABOUT SPEAKERS PROGRAMME REGISTRATION CONTACT LOCATION About the workshop ParaFrap is organizing the ParaFrap Next Generation in Parasitology...
Monday, 29 April 2024MA. Hakimi, laureate of the Excellence Chair in Biology/Health France 2030
[Communiqué] As part of the actions of the Health Innovation Plan 2030, the health component of the France 2030 plan, Mohamed-Ali Hakimi is one of the 22 laureates of an Excellence Chair in Biology/Health, supported to conduct high-level research...
Tuesday, 16 April 2024Seminar - Boris Striepen - May 24
The York Biomedical Research Institute (YBRI) are hosting an online live seminar on Friday 24th May 1-2pm BST as part of their biomedical science seminar series. You are all welcome to attend - registration is required via the...
Friday, 12 April 2024Arthur Talman received an ERC Advanced grant
[Communiqué] Congratulations to Arthur Talman, IRD Research Leader in the MIVEGEC laboratory (Montpellier), who has been awarded an Advanced Grant from the European Research Council (ERC) for the project "TROJAN - Molecular mimicry and immune...
Wednesday, 13 March 2024CNRS Bronze Medal for Ana Rita GOMES
Ana Rita Gomes, a CNRS Research Associate at the Laboratory of Pathogens and Host Immunity in Montpellier, and former Postdoctoral fellow of the LabEx ParaFrap, has been awarded the prestigious CNRS Bronze Medal in 2023. This...
Sunday, 07 January 2024Webinars 2024
Happy New Year 2024! To kick off this new scientific year, here is the ParaFrap webinar schedule. Since January 2021, ParaFrap has been organizing a series of webinars. This monthly event, held every 2nd Thursday of the month, aims to strengthen...
Wednesday, 13 December 2023New method to produce in vitro Toxoplasma pre-gametes
The team of Dr. Mohamed-Ali Hakimi, in collaboration with Isabelle Coppens (Johns Hopkins University Bloomberg School of Public Health and Malaria Research Institute, Baltimore, MD, USA), has developed a new (epi)genetic method to produce in vitro...
TRAINING PROGRAM
International PhD ProgramPostdoctoral ProgramNEWS
© 2023. All rights reserved MLCOM
Notre site LabEx ParaFrap utilise des cookies pour réaliser des statistiques de visites, partager des contenus sur les réseaux sociaux et améliorer votre expérience. En refusant les cookies, certains services seront amenés à ne pas fonctionner correctement. Nous conservons votre choix pendant 30 jours. Vous pouvez changer d'avis en cliquant sur le bouton 'Cookies' en bas à gauche de chaque page de notre site. En savoir plus
Cookies settings
×Functional Cookies
Ce site utilise des cookies pour assurer son bon fonctionnement et ne peuvent pas être désactivés de nos systèmes. Nous ne les utilisons pas à des fins publicitaires. Si ces cookies sont bloqués, certaines parties du site ne pourront pas fonctionner.
Measure of audience
Ce site utilise des cookies de mesure et d’analyse d’audience, tels que Google Analytics et Google Ads, afin d’évaluer et d’améliorer notre site internet.
- Google Analytics
- Google Ads
Interactive Content
Ce site utilise des composants tiers, tels que NotAllowedScript6750a7bcc8be0ReCAPTCHA, Google NotAllowedScript6750a7bcc8758Maps, MailChimp ou Calameo, qui peuvent déposer des cookies sur votre machine. Si vous décider de bloquer un composant, le contenu ne s’affichera pas
- Google Maps
Pour en savoir plus, cliquez sur le lien.
See the official site - Calameo
Pour en savoir plus, cliquez sur le lien.
See the official site - reCaptcha V2
Pour en savoir plus, cliquez sur le lien.
See the official site - reCaptcha V3
Pour en savoir plus, cliquez sur le lien.
See the official site
Social Networks / Videos
Des plug-ins de réseaux sociaux et de vidéos, qui exploitent des cookies, sont présents sur ce site web. Ils permettent d’améliorer la convivialité et la promotion du site grâce à différentes interactions sociales.
- Twitter
Pour en savoir plus, cliquez sur le lien.
See the official site
Session
Please login to see yours activities!Other cookies
Ce site web utilise un certain nombre de cookies pour gérer, par exemple, les sessions utilisateurs.
